Targeting tyrosine-kinases in ovarian cancer

Author： Morotti Matteo Becker Christian M Menada Mario Valenzano Ferrero Simone

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.10, 2013-10, pp. : 1265-1279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Aurora kinases in ovarian cancer

By Fu Siqing Hu Wei Kavanagh John J Bast Jr Robert C

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 77-85

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic targeting of receptor tyrosine kinases in lung cancer

By Choong Nicholas W Ma Patrick C Salgia Ravi

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 533-559

Informa Healthcare

Access to resources Recommend Favorite

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

Current Drug Targets, Vol. 17, Iss. 14, 2016-11 ,pp. : 1687-1703

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Targeting Neuregulin1 and HER Receptor Tyrosine Kinases for Therapy of Breast Cancer and Heart Failure

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4854-4855

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias

By Banerji Lolita Sattler Martin

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 3, 2004-06 ,pp. : 221-239

Informa Healthcare

Access to resources Recommend Favorite